ClinicalTrials.Veeva

Menu

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

C

Copenhagen University Hospital at Herlev

Status

Unknown

Conditions

Bladder Cancer

Treatments

Procedure: Identifying genes methylated in urine

Study type

Observational

Funder types

Other

Identifiers

NCT00244205
Blæretumor PCR projekt

Details and patient eligibility

About

To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with bladder tumors and patients with benign urinary tract conditions with no clinical suspicion of bladder cancer.

Exclusion criteria

  • Patients with competing urinary and systemic diseases, pregnant and patients under 18 years of age.

Trial contacts and locations

1

Loading...

Central trial contact

Jørgen H Andersen; Reza R Serizawa, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems